April 9, 2024
by Bohdana Sokolova
Biopharma insight
The world of clinical trials is undergoing an evolution as the rise of decentralized clinical trials (DCTs) brings about a change …
April 8, 2024
by Andrii Buvailo
Biopharma insight
Sponsored by Lantern Pharma
Clinical trials are the lifeline of modern medicine, bridging the gap between lab-borne scientific discoveries and the availability of life-saving …
April 8, 2024
by Dimitrios Skaltsas, Bara Badwan, Panos Karelis
Sponsored by Intelligencia AI
Fierce competition. Thin pipelines. Patent cliffs. The stakes are sky-high for pharmaceutical companies and investors alike. With biotech firms often …
April 7, 2024
by Andrii Buvailo, PhD
Biopharma insight
In a detailed interview, Dr. Brian Jamieson, founder and CTO of Diagnostic Biochips (DBC), delves into the evolving landscape of …
April 3, 2024
by BiopharmaTrend
News
In a first-of-its kind analysis, BiopharmaTrend is excited to announce the release of its seminal report, "It’s Been a Decade …
April 1, 2024
Case study
Sponsored by Trialize
In the realm of clinical trials, efficient data management and monitoring are crucial yet often hampered by outdated and time-consuming …
March 27, 2024
by Andrii Buvailo, PhD
News
In a collaborative effort between Brainomix, an AI-powered medical technology company, and AstraZeneca, a new study demonstrates significant advancements in …
March 25, 2024
by Andrii Buvailo, PhD
Biopharma insight
The biotech industry is experiencing a big wave of investment, similar to the high levels seen between 2020 and 2021. …
March 19, 2024
by Andrii Buvailo, PhD
Biopharma insight
NVIDIA's CEO, Jensen Huang, recently outlined the company's expanded focus on software solutions designed to facilitate the adoption of artificial …
March 19, 2024
by Andrii Buvailo, PhD
News
Denmark is set to create a national AI innovation centre in collaboration with NVIDIA, aiming to host one of the …
The field of AI ligand pose prediction in the protein binding pockets (aka “AI docking”) witnessed unprecedented development in the …
March 18, 2024
by Irina Bilous
Biopharma insight
Historically, the approval rate for medicines treating central nervous system (CNS) disorders was low. By 2022, the success rate for …